Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On February 10, 2026, the Company issued a press release titled "Transdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles b
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated February 10 , 2026, titled “Transdermal GFR Article Recognized